< Back to latest news & events

Event

Innovate Oxford: Healthcare Investor Networking Reception

November 2024

Event date: 18th November 2024

HGF are proud to be attending the Innovate Oxford: Healthcare Investor Networking Reception in London.

The Networking Reception will be held at the National Theatre, Southbank, London on 18th November.

This event is an opportunity for investors from London and beyond to explore the innovative healthcare landscape emerging from Oxford. There will be an opportunity to discover investment opportunities, meet investors. There will also be a networking reception to network with leaders within the industry.

Partner and Head of Chemistry Andrew Wells will be speaking on ‘Investment in the healthcare landscape’.

Partner and Head of Life Sciences Kate Taylor and Patent Director Sofie McPherson will also be attending.

FIND OUT MORE

Attendees

Andrew
Wells

Kate
Taylor

Sofie
McPherson

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

HGF ranked highly recommended in the WIPR Trade Mark Rankings 2025

HGF has been recognised as a leading firm in the recently published World IP Review (WIPR) Trade Mark Rankings 2025. This achievement highlights our continued commitment to excellence in trade …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article
See all updates